09 Nov 2026, 06:19 IST
Divi's Laboratories Limited
HDFC Securities · ADD · target INR 11,470
The note says Divi's Q2 EBITDA beat estimates on 35% YoY sales growth and margin expansion, leading HSIE to raise EBITDA estimates and revise its target price to INR 11,470 while maintaining ADD.
From HSIE Results Daily 09 Nov 26 HSIE, written by HDFC Securities. Orivam summarised it; the view is HDFC Securities's, not Orivam's.
Open the original PDF →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.